significantTreatment update
EULAR/PReS 2024 updated management recommendations published
Familial Mediterranean Fever →Summary
Ozen et al. published the 2024 update to EULAR recommendations for FMF management, including 4 overarching principles and 12 specific recommendations. Colchicine should be initiated immediately upon clinical diagnosis. IL-1 inhibitors recommended for inadequate colchicine response. Colchicine confirmed safe in pregnancy.
Related treatments
More from Familial Mediterranean Fever
significantTreatment update
JAK inhibitors (tofacitinib) emerging as potential third-line therapy
significantTreatment update
IL-1 blockade established as standard second-line therapy for colchicine-resistant FMF
significantNew research
Colchicine resistance mechanisms linked to pyrin inflammasome microtubule independence
incrementalGenetic finding
SAA1 gene polymorphisms identified as independent amyloidosis risk modifier
ID: familial-mediterranean-fever-update-1Type: treatment_updateImpact: significant